The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Transition metal complexes as photosensitizers for integrated cancer theranostic applications
Abstract
Abstract Light, oxygen and photosensitizers (PSs) are the three separate elements that have been applied in combination in the phototherapy of cancers in the past decades. Currently, platinum (Pt)-based drugs still account for approximately 50% of traditional chemotherapies used in the clinic. Transition metal complexes with unique and versatile photochemical and photophysical properties have appeared as promising systems for both photodynamic therapy and photoactivated chemotherapy. The highly potent photobiological activity based on energy transfer and electron transfer processes takes advantage of these properties. In this perspective article, we discuss the development of transition metal complexes (TMCs) with meaningful designs for the diagnosis and therapy of malignant tumors, including octahedral Ru(II) (ruthenium), Pt(IV) and Rh(III) (rhodium) PSs and in the early stages of Ir(III) (iridium) and Os(II) (osmium) complexes. The combination of organometallics with other active targeting moieties, such as antibodies, peptides, and aptamers, resulting in increased selectivity and reduced side-effects, will then be discussed. The challenges and future perspectives in this field will also be discussed. This review not only provides useful information for the future design of chemically innovative TMC-based anticancer drug candidates with clear mechanisms of action and drug targets, but also sheds light into the discovery of metal-based PSs to improve cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting hypoxia in cancer therapy
Wilson, W. R., & Hay, M. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3064 · Cited by 3,172
O’Connor, A. E., Gallagher, W. M., & Byrne, A. T. (2009) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2009.00585.x · Cited by 1,191
Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model
Castano, A. P., Mroz, P., Wu, M. X., & Hamblin, M. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709256105 · Cited by 201
Cited by
Mito‐Bomb: Targeting Mitochondria for Cancer Therapy
Guo, X., Yang, N., Ji, W., Zhang, H., Dong, X., Zhou, Z., Li, L., Shen, H., Yao, S. Q., & Huang, W. (2021) · Advanced Materials · doi:10.1002/adma.202007778 · Cited by 421
Supramolecular cancer nanotheranostics
Zhou, J., Rao, L., Yu, G., Cook, T. R., Chen, X., & Huang, F. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00011f · Cited by 411
Li, C., Pang, Y., Xu, Y., Lu, M., Tu, L., Li, Q., Sharma, A., Guo, Z., Li, X., & Sun, Y. (2023) · Chemical Society Reviews · doi:10.1039/d3cs00227f · Cited by 157
Design strategies and applications of cyanine dyes in phototherapy
Yuan, J., Yang, H., Huang, W., Liu, S., Zhang, H., Zhang, X., & Peng, X. (2025) · Chemical Society Reviews · doi:10.1039/d3cs00585b · Cited by 143
Yang, Y., Chen, K., He, X., Han, H., Li, L., Li, M., & Shen, Q. (2024) · ACS Applied Nano Materials · doi:10.1021/acsanm.4c02918 · Cited by 12
Metadata
- Authors
- Li, J., & Chen, T.
- Venue
- Coordination Chemistry Reviews
- Publisher
- Elsevier BV
- Published
- 2020-09
- Volume
- 418
- Pages
- 213355
- ISSN
- 0010-8545 (ISSN-L)
- OpenAlex
- W3033124744
- Cited by
- 176
- References
- 3
- FWCI
- 7.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Transition metal complexes as photosensitizers for integrated cancer theranostic applications. https://app.cochat.ai/papers/10.1016/j.ccr.2020.213355
- The paper
- Li, J., & Chen, T. (2020). Transition metal complexes as photosensitizers for integrated cancer theranostic applications. Coordination Chemistry Reviews. https://doi.org/10.1016/j.ccr.2020.213355
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.